-DOCSTART- -X- O
Vaccine -X- _ O
studies -X- _ O
for -X- _ O
Shigella -X- _ O
flexneri -X- _ O
and -X- _ O
enterotoxigenic -X- _ O
Escherichia -X- _ O
coli -X- _ O
have -X- _ O
been -X- _ O
impaired -X- _ O
by -X- _ O
the -X- _ O
lack -X- _ O
of -X- _ O
optimal -X- _ O
animal -X- _ O
models. -X- _ O
We -X- _ O
used -X- _ O
two -X- _ O
murine -X- _ O
models -X- _ O
to -X- _ O
show -X- _ O
that -X- _ O
a -X- _ O
S. -X- _ B-Intervention
flexneri -X- _ I-Intervention
2a -X- _ I-Intervention
bivalent -X- _ I-Intervention
vaccine -X- _ I-Intervention
( -X- _ I-Intervention
CVD -X- _ I-Intervention
1208S-122 -X- _ I-Intervention
) -X- _ I-Intervention
expressing -X- _ I-Intervention
enterotoxigenic -X- _ I-Intervention
Escherichia -X- _ I-Intervention
coli -X- _ I-Intervention
colonization -X- _ I-Intervention
factor -X- _ I-Intervention
antigen-I -X- _ I-Intervention
( -X- _ I-Intervention
CFA -X- _ I-Intervention
/ -X- _ I-Intervention
I -X- _ I-Intervention
) -X- _ I-Intervention
and -X- _ I-Intervention
the -X- _ I-Intervention
binding -X- _ I-Intervention
subunits -X- _ I-Intervention
A2 -X- _ I-Intervention
and -X- _ I-Intervention
B -X- _ I-Intervention
of -X- _ I-Intervention
heat -X- _ I-Intervention
labile-enterotoxin -X- _ I-Intervention
( -X- _ I-Intervention
LTb -X- _ I-Intervention
) -X- _ I-Intervention
is -X- _ O
immunogenic -X- _ O
and -X- _ O
protects -X- _ B-Outcome
against -X- _ I-Outcome
weight -X- _ I-Outcome
loss -X- _ I-Outcome
and -X- _ I-Outcome
diarrhea. -X- _ I-Outcome
These -X- _ O
findings -X- _ O
document -X- _ O
the -X- _ O
immunogenicity -X- _ O
and -X- _ O
pre-clinical -X- _ O
efficacy -X- _ O
effects -X- _ O
of -X- _ O
CVD -X- _ B-Intervention
1208S-122 -X- _ I-Intervention
vaccine -X- _ I-Intervention
and -X- _ O
suggest -X- _ O
that -X- _ O
further -X- _ O
work -X- _ O
can -X- _ O
help -X- _ O
elucidate -X- _ O
relevant -X- _ O
immune -X- _ O
responses -X- _ O
and -X- _ O
ultimately -X- _ O
its -X- _ O
clinical -X- _ O
efficacy -X- _ O
in -X- _ O
humans -X- _ O
. -X- _ O

